Interferon (IFN)-c was originally characterized as a pro-inflammatory cytokine with T helper type 1-inducing activity, but subsequent work has demonstrated that mice deficient in IFN-c or IFN-c receptor show exacerbated inflammatory responses and accelerated allograft rejection, suggesting that IFN-c also has important immunoregulatory functions. Here, we demonstrate that ex vivo IFN-c conditioning of CD4 T cells driven by allogeneic immature dendritic cells (DC) results in the emergence of a Foxp3 1 regulatory T-cell (Treg)-dominant population that can prevent allograft rejection. The development of this population involves conversion of non-Treg precursors, preferential induction of activation-induced cell death within the non-Treg population and suppression of Th2 and Th17 responses. The suppressive activity of IFN-c is dependent on the transcription factor signal transducer and activator of transcription 1 and is mediated by induced nitric oxide. These data indicate not only how IFN-c could be used to shape beneficial immune responses ex vivo for possible cell therapy but also provide some mechanistic insights that may be relevant to exacerbated inflammatory responses noted in several autoimmune and transplant models with IFN-c deficiency.
Introduction
The role of interferon (IFN)-g in cellular immunity is somewhat paradoxical in that, although it is usually considered to be a pro-inflammatory effector cytokine, increasing evidence suggests that it plays a non-redundant immunoregulatory role. For example, experimental autoimmune encephalomyelitis (EAE) and collagen-induced arthritis (CIA) have been historically associated with IFN-g-producing Th1-dominant responses [1] , but mice deficient in IFN-g or IFN-g receptor develop EAE at an accelerated rate [2] [3] [4] and, similarly, deficiency in IFN-g or IFN-g receptor leads to more severe CIA and the development of CIA in otherwise non-susceptible strains [5] [6] [7] . IFN-g can also have immunomodulatory effects on antigen-presenting cells and a recent report has demonstrated that adoptive transfer of IFN-g-stimulated monocyte-derived cells promotes the resolution of experimental colitis and is associated with an enrichment of CD25 1 Foxp3
1
T cells [8] .
A paradoxical role for IFN-g is also seen in organ transplantation [9] [10] [11] . Allograft rejection is a process frequently associated with a dominant Th1 IFN-g response whereas the absence of intragraft IFN-g often correlates with long-term graft survival [12, 13] . However, IFN-g appears not to be essential for acute cellular rejection as both IFN-g-deficient and wild-type mice reject cardiac allografts with similar kinetics [14, 15] and at least one study has demonstrated that IFN-g À/À recipients reject skin allografts more rapidly than their wild-type littermates [9] . In fact, IFN-g may be required for successful engraftment [9, 16, 17] . Although the classical view of IFN-g is that it favors Th1 cell development [18, 19] , IFN-g also has regulatory functions. For example, IFN-g can inhibit the proliferation of IL-4-producing Th2 cells [20] and suppress the development of Th17 effector cells now known to play an important role in many autoimmune models [21, 22] . In addition, IFN-g also plays an important role in maintenance of T-cell homeostasis by inducing apoptosis-dependent activation-induced cell death (AICD) to limit T-cell expansion following antigen encounter [23] [24] [25] [26] [27] [28] . In the context of adaptive regulation, we have recently shown that IFN-g is produced rapidly and transiently by alloantigen-reactive Treg following reactivation and that this is required for their functional activity in vivo [29] . IFN-g can induce indoleamine 2,3-dioxygenase in several cell types and this enzyme has been shown to play an important role in limiting T-cell responses in vivo [30] [31] [32] .
In this study, we demonstrate that ex vivo exposure of CD4

T cells to allogeneic bone marrow-derived dendritic cells (DC) in the presence of IFN-g results in a
Treg population that prevents allograft rejection without further manipulation. The data indicate that IFN-g shifts the balance of the T-cell population in favor of an enhanced proportion of Foxp3 1 Treg by selectively enhancing cell death in the non-Treg population and by promoting direct conversion of non-Treg precursors. Experiments using DC from IFN-g receptor-deficient mice demonstrate that this does not depend on a DC response to IFN-g but that T-cell signalling through the signal transducer and activator of transcription (STAT)1 pathway is essential for the emergence of a dominant Treg response. Significantly, inhibition of nitric oxide synthase (NOS) abolishes the emergence of the dominant Treg response and provision of a nitric oxide (NO) donor in the absence of IFN-g replicates the IFN-g effect, clearly indicating an important role for NO in this process. Overall, the data highlight a novel role of IFN-g in the regulation of T-cell homeostasis and suggest additional possibilities for cell-based therapy in transplantation and autoimmunity.
Results
IFN-c promotes the enrichment of functional Foxp3 1 Treg
The counter-regulation of Th2 and Th17 responses mediated by IFN-g, together with previous observations from this laboratory indicating that Treg generation in vivo is impaired in the absence of IFN-g [29] , prompted us to ask whether this cytokine could be used to drive the emergence of alloreactive regulatory T cells ex vivo. 
/Foxp3
À cells by flow sorting.
As shown in Fig. 2D , the presence of IFN-g enhances cell death within the Foxp3 -population at days 7, 10 and 14, but a more comprehensive analysis at day 14 (the time of cell harvest for functional analysis; Fig. 1) showed that within the total T-cell population, the addition of IFN-g resulted in a threefold increase in the proportion of annexin V 1 cells. Importantly, when cells were analyzed separately on the basis of Foxp3 expression, exogenous IFN-g had little effect on the viability of Foxp3 1 cells (6.372.7 versus 9.574.3%, absence and presence of IFN-g, respectively) but resulted in a sixfold increase in cell death within the Foxp3 -population (right panel, Fig. 2D ). Taken together, these data show that the increased proportion of Foxp3 1 cells and acquisition of regulatory function that occurs in this system involves both Treg conversion and elimination of potential effector cells through AICD. However, it is important to note that the ability of the resultant population to prevent allograft rejection ( Fig. 1D) is not due to effector cell elimination during ex vivo conditioning because in the adoptive transfer model, an adequate effector population is provided in the form of exogenous naive CD25 À T cells. Thus, the dominant regulation shown in Fig. 1D appears to be a direct consequence of Foxp3 induction.
Suppression of IL-6 production by DC contributes to Treg generation ex vivo
The IFN-g-conditioning system described involves two distinct phases: conditioning of BM DC with GM-CSF and TGF-b followed by stimulation of naive CD4 1 T cells with this re-isolated DC population in the presence of IFN-g. To understand more about the mechanisms involved in this protocol, we interrogated the APC and T-cell components of this system independently. Although mature DC are regarded as key activators of productive T-cell responses, exposure to immature DC can induce T-cell unresponsiveness [34] . Phenotypic analysis of DC conditioned with GM-CSF or GM-CSF1TGF-b confirmed previous observations [35] that one effect of TGF-b is to maintain these cells in a relatively immature state as judged by reduced expression of CD40, CD80 and CD86 (not shown). In view of the fact that GM-CSF-conditioned DC produce significant amounts of IL-6, a cytokine implicated in the differentiation of Th17 cells and the negative regulation of Treg [33] , we asked whether conditioning of DC with TGF-b also has an effect on IL-6 expression. BM DC were conditioned with GM-CSF only or with GM-CSF1TGF-b for 6 days, washed extensively, then stimulated with recombinant CD40L-Fc to mimic CD40-CD40L interactions without the confounding influence of other T-cell-APC interactions, and analyzed for IL-6 expression by both RT-PCR and ELISA. As shown in Fig. 3A , the addition of 2 ng/mL TGF-b as used in the DC-conditioning phase reduced both the transcription and secretion of IL-6 by approximately threefold. Since DC conditioned in the absence of TGF-b do not promote the emergence of a Foxp3-dominant response in the IFN-g protocol (not shown), these data indicate that reduced IL-6 production is an important additional characteristic of the DC required for Treg development in this system. Furthermore, when GM-CSF-TGF-b-conditioned DC obtained from IL-6-deficient mice were used to stimulate CBA CD4 1 T cells in the normal IFN-g protocol, there was a twofold increase in the proportion of Foxp3 1 cells recovered (Fig. 3B) , again highlighting the reciprocal relationship between IL-6 and Treg selection in this setting.
The influence of TGF-b on IL-6 production in the APC population used in this conditioning protocol prompted us to examine the differentiation of Th17 cells, both under neutral conditions and in the presence of IFN-g. As shown in Fig. 4 , naive CBA CD4 1 cells stimulated under neutral conditions with GM-CSF-conditioned DC make dominant Th2 and Th17 responses as judged by intracellular cytokine staining. However, when the same T-cell population is stimulated under identical conditions but with DC conditioned with GM-CSF1TGF-b these responses are reduced 4-6-fold, indicating that one important effect of TGF-b conditioning of the APC population is to skew the T-cell response away from both Th2 and Th17 pathways. It is interesting to note that, while the addition of IFN-g has only a modest further effect on inhibition of Th17 responses, the production of IL-4 is reduced essentially to background levels. Thus, in addition to an enrichment of [40, 41] . Cells were restimulated on day 7, harvested on day 14, and intracellular Foxp3 expression was analyzed. As shown in Fig. 5B and without IFN-g, respectively; Fig. 6D ). In fact, the proportion of Foxp3 1 cells was essentially the same as that seen when neither cell population was capable of responding to IFN-g (Fig. 6B) . Similar results were obtained using wild-type or Stat1 À/À 129 CD4 1 T cells stimulated with GM-CSF/TGF-b BM DC from CBA (H2 k ) mice at each concentration of IFN-g tested ( Fig. 6E and F) . Taken together, these results indicate that, in the IFN-g-conditioning protocol described, T-cell signalling via STAT1 is essential for the enrichment of Foxp3 1 T cells.
Non-redundant role for STAT1 signalling in Th17 and
Cytokine signalling through STAT transcription factors is essential for T-cell differentiation. For instance, STAT4 and STAT6 are historically linked with Th1 and Th2 development, respectively, while more recently STAT3 has been linked with the development of Th17 cells and STAT5 with regulatory T cells [44] . We wished to examine the impact of STAT1 deficiency on the emergence of Foxp3 1 and Th17
T cells in the presence of IFN-g, particularly since it has been shown that Th17 cell development is enhanced in 
Stat1
À/À mice [45] . In the absence of exogenous cytokines (neutral conditions), Th17 cell development was enhanced in Stat1 À/À T cells (Fig. 7A versus B Foxp3 expression in the ex vivo IFN-g-conditioning system (data not shown). In order to ask whether NO is directly involved in the IFN-g-conditioning protocol, naive CBA CD4 1 T cells were cocultured with GM-CSF/TGF-b B10 BM DC in the presence of IFN-g (5 ng/mL), with or without N-methyl-L-arginine (L-NMMA) (0.1-1.0 mM), a widely used inhibitor of both constitutive and inducible forms of NOS [48, 49] . Cells were restimulated on day 7, harvested on day 14, and intracellular Foxp3 expression was analyzed. In the absence of L-NMMA, the proportion of inhibitor. These data indicate that induced NO plays an essential role in the development of Foxp3
1 Treg driven by IFN-g conditioning.
We then asked whether a non-cellular source of NO could substitute for exogenous IFN-g in the ex vivo conditioning protocol. Naive CBA CD4
1 T cells were co-cultured with GM-CSF/TGF-b B10 BM DC in the absence of exogenous IFN-g but with or without S-nitroso-N-acetyl-penicillamine (SNAP), a NO donor widely tested ex vivo [48, 50, 51] . Cells were restimulated on day 7 under the same conditions, harvested on day 14, and intracellular Foxp3 expression was analyzed.
As shown in Fig. 8B mediating the development of Foxp3 1 cells driven by alloantigen in the IFN-g-conditioning protocol. Interestingly, at optimal concentrations of either exogenous IFN-g or NO donor, the proportion of Foxp3 1 cells was similar, but the provision of NO increased the yield of both total cells and Treg. This is partly explained by the fact that, as judged by annexin V staining, the level of cell death seen in the presence of the optimal concentration of NO donor (0.3 mM) is substantially lower than that seen in the presence of the optimal concentration of IFN-g (7.974.0 and 16.678.0% for 1SNAP and 1IFN-g, respectively; not shown), further reflecting the fact that exogenous IFN-g in this system reduces the overall size of the responding T-cell pool due to its anti-proliferative and pro-apoptotic effects ( Fig. 2 and [23-25, 27, 28] ). Indeed, an overall reduction in the size of the responding T-cell population may be an important prerequisite for regulation [52, 53] .
Discussion
Treg cells generated or expanded ex vivo have significant potential as cellular therapeutics [54] . Several such ex vivo protocols exist [37, 38, 55] and understanding the underlying mechanisms responsible for Treg generation will have an important influence in optimizing and identifying the most suitable protocols for clinical evaluation. In the current study, we have demonstrated that stimulation of mouse 
Foxp3
-cells will be assessed independently for functional regulatory capacity. We hope that this will allow us to determine definitively whether or not regulation is confined to alloantigen-driven Foxp3 1 T cells.
The addition of exogenous IFN-g appears to result in an overall selection for cells with a Treg phenotype via proliferation, conversion of non-Treg precursors and induction of cell death within the responding non-Treg population, but we have found little evidence for an increase in the absolute size of the Foxp3 1 population compared with that recovered under identical conditions in the absence of IFN-g. Despite this, the resulting cells regulate rejection in an alloantigen-specific manner and we speculate that alloantigen stimulation by GM-CSF/TGF-b BM DC in the presence of IFN-g drives an overall shift in the specificity of Foxp3 1 cells, resulting in a relatively oligoclonal population in much the same way as repeated in vitro stimulation selects for the survival of responding non-regulatory T cells in other settings. We are currently attempting to test this hypothesis by seeding TCR-transgenic T cells into polyclonal populations followed by alloantigen challenge in the presence of IFN-g. When total CD4 1 T cells are used as the input population, there is clear evidence of preferential apoptosis or necrosis within non-Treg responders (Fig. 2D) . The fact that IFN-g can enhance apoptosis within activated T-cell populations has been known for many years [23] [24] [25] stimulus expected to provide supra-optimal T-cell activation (data not shown). Indeed, it was on this basis that GM-CSF/TGFb-conditioned BM-derived DC were chosen as the preferred APC population in the IFN-g-conditioning protocol because this pretreatment arrests DC maturation and retards MHC and costimulatory molecule upregulation. While we have not formally tested whether other isolated APC populations can also drive the selection of Foxp3 1 Treg in the IFN-g protocol, previous attempts using T-cell-depleted spleen cells as APC gave extremely unpredictable results. However, it seems likely that other immature APC would be capable of inducing the generation of Treg in this system, particularly if they retained the capacity for production of TGF-b (Fig. 5) . It would be expected that suboptimally activated T cells would be less susceptible to AICD and, indeed, we have found, using CFSE-based assays, a clear correlation between T-cell proliferation and death in the IFN-g conditioning protocol (data not shown). Furthermore, the fact that Treg tend to be anergic might also confer a relative resistance to AICD. An additional possibility is that alloantigen-driven Treg have an increased expression of anti-apoptotic molecules such as Bcl-x L , as has recently been reported in naturally occurring Foxp3 GM-CSF/TGF-b-differentiated DC tend to have an intrinsic bias toward Th2 and Th17 responses because these APC produce significant amounts of both TGF-b and IL-6. Significantly, this bias is prevented by the addition of exogenous IFN-g without resulting in an overt Th1 response (Fig. 4) , an observation entirely consistent with previous studies [58] [59] [60] . Again, these data suggest that IFN-g selectively inhibits development of the effector T-cell population while maintaining the development of Treg. Thus, the effect of exogenous IFN-g in this system is to influence the development of a dominant Treg response by inducing death within Foxp3 -responders and by skewing the overall T-cell response away from Th2 and Th17 cells. In this context, it is interesting to note that, in a rather different ex vivo system where the emergence of Foxp3 1 T cells is dependent on exogenous TGF-b [61] , IL-4 appears to be more antagonistic than IFN-g. This appears to be consistent with observations in the current study where one of the effects of exogenous IFN-g is to inhibit Th2 development (Fig. 4) . Our data show that NO is critically involved in the ex vivo IFNg-conditioning protocol. IFN-g is an efficient inducer of NOS activity [46] , an observation consistent with the described effects of NO, an important effector molecule in immunity, particularly against intracellular pathogens. However, data are emerging indicating that NO also plays a regulatory role in immune responses [62] . For example, iNOS-mutant mice develop significantly more pronounced Th1 responses than wild-type mice upon infection, and IFN-g-induced NO can downregulate Bcl-2 expression and induce apoptosis of primed T cells [63, 64] . Williams et al. have shown that T cells can produce NO upon TCR signalling and that this is closely involved in AICD [65] . In addition, NO can induce upregulation of IFN-g receptor 2 expression on T cells, and these T cells are thus susceptible to IFN-g [66] . IFN-g receptor signalling with subsequent STAT1 phosphorylation is critical for the function of IFN-g [42, 43] . Stat1 À/À mice develop EAE and show enhanced generation of Th1 cells, suggesting that STAT1 signalling is not only non-obligatory for Th1 development but may play a negative feedback role on effector cell responses [67, 68] . A potential explanation for such observations has recently been provided by studies demonstrating that Stat1 À/À mice have enhanced Th17 responses [45] , indicating that STAT1 signalling plays a critical negative role in Th17 cell differentiation. Indeed, both IFN-g and IL-27 have been shown capable of suppressing Th17 development via signalling through STAT1 [69] and a recent report has demonstrated that STAT1 phosphorylation can lead to the transcription of iNOS [47] . Our data demonstrate that NO can play an important role as a downstream mediator of this effect since inhibition of NOS completely abrogated IFN-g conditioning and provision of an NO donor in the absence of exogenous IFN-g also resulted in a Foxp3 1 Treg-dominant response.
The data presented in this study provide novel insights into the means and mechanism by which a dominant alloreactive regulatory T-cell population can be encouraged to develop ex vivo. The fact that the protocol results in partial selection of regulatory cells by shifting the balance between Treg and nonTreg populations suggests that, if used in concert, the IFN-g protocol followed by polyclonal expansion might provide sufficient numbers of enriched regulatory cells for therapeutic use. Indeed, in this regard the preferential elimination of alloreactive non-Treg cells might confer a significant benefit. Recently, two other independent studies have demonstrated that exogenous IFN-g can be used to influence Treg development ex vivo. In the first, Wang et al. demonstrated that polyclonal activation of mouse CD4
1
CD25
À T cells with anti-CD3 antibody in the presence of IFN-g resulted in a population of CD25 1 T cells that inhibited the development of EAE almost as effectively as naturally occurring Treg [70] . In the second study, Brem-Exner et al.
showed that exposure of lymph node cells in vitro to IFN-gconditioned monocytes led to an expansion of CD25 1
Foxp3
1
T cells, and while the ability of these ex vivo generated/expanded cells to regulate responses in vivo was not formally tested, the fact that adoptive transfer of the IFN-g-conditioned monocyte population led to a resolution of colitis in a mouse model of inflammatory bowel disease is consistent with an in vivo conversion driven by this APC population [8] .
The results of the current study extend these observations significantly by demonstrating that IFN-g can be used to shape the ex vivo T-cell response to alloantigens away from effector cell differentiation in favor of Treg development and that without further manipulation the resultant population can control acute allograft rejection. Although such approaches have potential therapeutic use in both transplantation and autoimmune disease, we believe that transplantation offers the unique advantage that APC from the graft donor can be used to drive Treg selection. Such antigen-specific activation is unlikely to be possible in autoimmunity, except in those cases where the antigens are well defined. Although living donor transplantation offers the most immediate possibility for donor-reactive Treg generation, the observation that some immunosuppressive agents are permissive and may select for regulatory T cells [55] suggests the possibility of combining Treg generation with short-course immunosuppression, to extend this type of approach to deceased donor transplantation. [33] . Sex-matched mice between 6 and 12 wk of age at the time of first experimental procedure were used in all experiments.
Materials and methods
Reagents and mAb
The hybridomas TIB120 (anti-MHC class II) and RA3.6B2 (anti-B220) were obtained from the American Type Culture Collection; YTS169 (anti-CD8) and YTA3.1 (anti-CD4) [71] In vitro generation of BM DC BM DC were generated from donor mice according to published methods [35, 72] . DC precursor-enriched BM cells were cultured with 2 ng/mL each of rmGM-CSF and rhTGF-b1 (PeproTech, London, UK). At day 6, DC were harvested, washed and counted prior to use.
IFN-c-conditioning protocol
Cell culture used RPMI 1640 containing 10% FCS, 2 mM L-glutamine, 0.5 mM 2-mercaptoethanol (Sigma) and 100 U/mL of penicillin and streptomycin (Sigma). Purified naive CD4 
Statistical analysis
Graft survival between transplant groups was compared using Kaplan-Meier survival curves and the Log-rank test (GraphPad Prism) with significance at po0.05. Two-tailed comparisons were made using the Mann-Whitney test.
